In vivo 2H-MR spectroscopy and imaging of hepatic metabolic formation of trimethylamine-N-oxide

Abstract

Purpose

Despite growing evidence of the link between elevated levels of trimethylamine-N-oxide (TMAO) and multiple diseases, there is no method with which to spatially monitor its hepatic formation from the interstitially produced trimethylamine (TMA). This study aimed to develop a deuterium metabolic spectroscopy (DMS) and imaging (DMI) approach to detect the TMA-to-TMAO metabolism in vivo.

Methods

The metabolism of ²H₉-TMA (TMA-d₉) to ²H₉-TMAO (TMAO-d₉) in cells overexpressing the hepatic enzyme flavin-dependent monooxygenase 3 (FMO3) was monitored in vitro with ²H-NMR. Using an ultrahigh-field (15.2T) MRI scanner, the hepatic metabolism of the orally administered TMA-d₉ to TMAO-d₉ was studied in mice with DMS and DMI.

Results

The spectrally resolved ²H-NMR peaks of intracellularly produced TMAO-d₉ (3.1 ppm) from that of supplemental TMA-d₉ (2.7 ppm) could be detected only in cells that overexpressed FMO3. In vivo, DMS and DMI experiments performed after oral administration of TMA-d₉ revealed the conversion to high TMAO-d₉ levels in the liver of females, which express high levels of FMO3. In contrast, there was no indication of TMAO-d₉ production in the liver of males, in agreement with reports of the role of testosterone in downregulating the expression of FMO3.

Conclusion

This work shows the ability to use ²H-MR-based methodologies to spatially monitor the TMA-to-TMAO metabolic pathway in vivo, and thus should be explored further to investigate the role of TMAO in diverse pathologies.